[1]
|
赵邱煜,信涛.非小细胞肺癌脑膜转移治疗的研究进展[J].医学综述,2021,27(2):303-307. doi: 10.3969/j.issn.1006-2084.2021.02.017
|
[2]
|
Sakurai T, Tuchida A, Nishida H. Significance of an epidermal growth factor receptor mutation in cerebrospinal fluid for leptomeningeal metastasis and successful treatment with osimertinib: A case report and literature review[J]. eNeurologicalSci, 2020, 8(22):303.
|
[3]
|
张萍,聂鑫,李旭,等.脑脊液ctDNA检测结果指导治疗肺癌脑转移1例[J].中国肿瘤临床,2018,45(6):320. doi: 10.3969/j.issn.1000-8179.2018.06.007
|
[4]
|
Pan Z, Yang G, Cui J, et al. A pilot phase 1 study of intrathecal pemetrexed for refractory leptomeningeal metastases from non-small-cell lung cancer[J]. Front Oncol, 2019, 30(9):838.
|
[5]
|
Sindeeva OA, Verkhovskii RA, Sarimollaoglu M, et al. New frontiers in diagnosis and therapy of circulating tumor markers in cerebrospinal fluid in vitro and in vivo[J]. Cells, 2019, 8(10):1195.
|
[6]
|
Pentsova EI, Shah RH, Tang J, et al. Evaluating cancer of the central nervous system through next-generation sequencing of cerebospinal fluid[J]. J Clin Oncol, 2016, 34(20):2404-2415.
|
[7]
|
朱立才,李明娟,王英,等.ctDNA对TKI靶向治疗EGFR突变型肺腺癌疗效及预后的预测价值[J].临床肺科杂志,2021,26(4):562-566. doi: 10.3969/j.issn.1009-6663.2021.04.017
|
[8]
|
张昆煜,戴朝霞,刘思雅,等.脑脊液ctDNA对非小细胞肺癌脑膜转移患者的临床价值[J].中国肺癌杂志,2020,23(12):1039-1048. doi: 10.3779/j.issn.1009-3419.2020.102.42
|
[9]
|
Meng Z, Zhang Q, Hong K, et al. Clinical outcome and prognostic analysis of meningeal carcinomatosis treated by intrathecal chemotherapy[J]. Expert Rev Pharmacoecon Outcomes Res, 2018, 18(4): 455-460.
|